American Family Physician - Albuterol vs. levalbuterol for asthma treatment in children
May 1, 2008 -- Purpose Each month, three presenters will review an interesting journal article in a conversational manner. These articles will involve
FOCUS: Journal for Respiratory Care & Sleep Medicine - New generic albuterol medication
May 1, 2006 -- Nephron Pharmaceuticals introduces the first and only FDA approved generic version of Albuterol Sulfate Inhalation Solution, 0.042% individually foil...
Business Wire - The Albuterol CFC to HFA Conversion - What is the Impact?
September 7, 2007 -- PALO ALTO, Calif. -- The Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive Healthcare 2007 Quarterly Analyst Briefing...
Pediatric News - Switch to HFA-propelled albuterol inhalers now, FDA advisory urges
August 1, 2008 -- In a public health advisory, the Food and Drug Administration is urging health care professionals and their patients and caregivers to switch to...
Internal Medicine News - Time is short to switch to HFA-propelled albuterol inhalers
July 1, 2008 -- In a public health advisory, the Food and Drug Administration urged health care professionals and their patients and caregivers to switch to...
FDA Consumer - Final rule on albuterol inhalers
July 1, 2005 -- After December 31, 2008, albuterol metered-dose inhalers (MDIs) using chlorofluorocarbon (CFC) propellants must no longer be produced, marketed, or...
American Family Physician - Levalbuterol and Albuterol equal for asthma in children
February 15, 2006 -- Clinical Question: In children with an acute moderate to severe asthma exacerbation, is levalbuterol (Xopenex) more effective and safer than...
Internal Medicine News - HFA-propelled albuterol safe for patients, Ozone
December 15, 2006 -- PHILADELPHIA -- Patients can be safely switched from chlorofluorocarbon-propelled albuterol to hydrofluoroalkane-propelled albuterol, with no...
Business Wire - Teva's ProAir® HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
September 23, 2008 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved ProAir([R]) HFA...
